{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:38Z","timestamp":1707525398276},"reference-count":64,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,13]]},"DOI":"10.7759\/cureus.48740","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T16:25:54Z","timestamp":1699892754000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Lynch Syndrome-Associated Colorectal Adenocarcinoma in a 19-Year-Old Female Patient"],"prefix":"10.7759","author":[{"given":"Aimen","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra K","family":"Rabat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravleen","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Waqas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanya","family":"Badar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faryal","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneebuddin","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0693","article-title":"Prevalence and penetrance of major genes and polygenes for colorectal cancer","volume":"26","author":"Win AK","year":"2017","unstructured":"Win AK, Jenkins MA, Dowty JG, et al.. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2017, 26:404-12. 10.1158\/1055-9965.EPI-16-0693","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.15.1114","article-title":"Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives","volume":"87","author":"Marra G","year":"1995","unstructured":"Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst. 1995, 87:1114-25. 10.1093\/jnci\/87.15.1114","journal-title":"J Natl Cancer Inst"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw322","article-title":"Colorectal cancer incidence patterns in the United States, 1974-2013","volume":"109","author":"Siegel RL","year":"2017","unstructured":"Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, Jemal A. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017, 109:djw322. 10.1093\/jnci\/djw322","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29716","article-title":"Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening","volume":"122","author":"Abdelsattar ZM","year":"2016","unstructured":"Abdelsattar ZM, Wong SL, Regenbogen SE, Jomaa DM, Hardiman KM, Hendren S. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016, 122:929-34. 10.1002\/cncr.29716","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181f20bd2","article-title":"Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria","volume":"252","author":"Kalady MF","year":"2010","unstructured":"Kalady MF, McGannon E, Vogel JD, Manilich E, Fazio VW, Church JM. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg. 2010, 252:507-11; discussion 511-3. 10.1097\/SLA.0b013e3181f20bd2","journal-title":"Ann Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0186","article-title":"Increase in incidence of colorectal cancer among young men and women in the United States","volume":"18","author":"Siegel RL","year":"2009","unstructured":"Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev. 2009, 18:1695-8. 10.1158\/1055-9965.EPI-09-0186","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00504","article-title":"Defining early-onset colon and rectal cancers","volume":"8","author":"Jacobs D","year":"2018","unstructured":"Jacobs D, Zhu R, Luo J, et al.. Defining early-onset colon and rectal cancers. Front Oncol. 2018, 8:504. 10.3389\/fonc.2018.00504","journal-title":"Front Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2017.11.13","article-title":"Age-related rates of colorectal cancer and the factors associated with overall survival","volume":"9","author":"Gabriel E","year":"2018","unstructured":"Gabriel E, Attwood K, Al-Sukhni E, Erwin D, Boland P, Nurkin S. Age-related rates of colorectal cancer and the factors associated with overall survival. J Gastrointest Oncol. 2018, 9:96-110. 10.21037\/jgo.2017.11.13","journal-title":"J Gastrointest Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.602","article-title":"Young-onset colorectal cancer: is it time to pay attention?","volume":"172","author":"You YN","year":"2012","unstructured":"You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention?. Arch Intern Med. 2012, 172:287-9. 10.1001\/archinternmed.2011.602","journal-title":"Arch Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309675","article-title":"Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database","volume":"66","author":"M\u00f8ller P","year":"2017","unstructured":"M\u00f8ller P, Sepp\u00e4l\u00e4 T, Bernstein I, et al.. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut. 2017, 66:464-72. 10.1136\/gutjnl-2015-309675","journal-title":"Gut"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3878","article-title":"Milestones of Lynch syndrome: 1895-2015","volume":"15","author":"Lynch HT","year":"2015","unstructured":"Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895-2015. Nat Rev Cancer. 2015, 15:181-94. 10.1038\/nrc3878","journal-title":"Nat Rev Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/ng.283","article-title":"Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1","volume":"41","author":"Ligtenberg MJ","year":"2009","unstructured":"Ligtenberg MJ, Kuiper RP, Chan TL, et al.. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet. 2009, 41:112-7. 10.1038\/ng.283","journal-title":"Nat Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1126\/science.8484122","article-title":"Microsatellite instability in cancer of the proximal colon","volume":"260","author":"Thibodeau SN","year":"1993","unstructured":"Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993, 260:816-9. 10.1126\/science.8484122","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona V","year":"2011","unstructured":"Bonadona V, Bona\u00efti B, Olschwang S, et al.. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011, 305:2304-10. 10.1001\/jama.2011.743","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp473","article-title":"Risks of Lynch syndrome cancers for MSH6 mutation carriers","volume":"102","author":"Baglietto L","year":"2010","unstructured":"Baglietto L, Lindor NM, Dowty JG, et al.. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010, 102:193-201. 10.1093\/jnci\/djp473","journal-title":"J Natl Cancer Inst"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0512","article-title":"Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening","volume":"17","author":"Poynter JN","year":"2008","unstructured":"Poynter JN, Siegmund KD, Weisenberger DJ, et al.. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev. 2008, 17:3208-15. 10.1158\/1055-9965.EPI-08-0512","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.041","article-title":"Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations","volume":"147","author":"Haraldsdottir S","year":"2014","unstructured":"Haraldsdottir S, Hampel H, Tomsic J, Frankel WL, Pearlman R, de la Chapelle A, Pritchard CC. Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. Gastroenterology. 2014, 147:1308-1316.e1. 10.1053\/j.gastro.2014.08.041","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00153","article-title":"Colorectal cancer in the adolescent and young adult population","volume":"16","author":"You YN","year":"2020","unstructured":"You YN, Lee LD, Deschner BW, Shibata D. Colorectal cancer in the adolescent and young adult population. JCO Oncol Pract. 2020, 16:19-27. 10.1200\/JOP.19.00153","journal-title":"JCO Oncol Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2010.06.006","article-title":"Clinical genetics of hereditary colorectal cancer","volume":"24","author":"Power DG","year":"2010","unstructured":"Power DG, Gloglowski E, Lipkin SM. Clinical genetics of hereditary colorectal cancer. Hematol Oncol Clin North Am. 2010, 24:837-59. 10.1016\/j.hoc.2010.06.006","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.20874","article-title":"Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing","volume":"120","author":"Terdiman JP","year":"2001","unstructured":"Terdiman JP, Gum JR Jr, Conrad PG, et al.. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology. 2001, 120:21-30. 10.1053\/gast.2001.20874","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24434","article-title":"Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer","volume":"115","author":"Jiang Y","year":"2009","unstructured":"Jiang Y, Kimchi ET, Staveley-O'Carroll KF, Cheng H, Ajani JA. Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer. Cancer. 2009, 115:3609-17. 10.1002\/cncr.24434","journal-title":"Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5201568","article-title":"Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor","volume":"14","author":"Plaschke J","year":"2006","unstructured":"Plaschke J, Linnebacher M, Kloor M, et al.. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor. Eur J Hum Genet. 2006, 14:561-6. 10.1038\/sj.ejhg.5201568","journal-title":"Eur J Hum Genet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.31070","article-title":"A novel MSH2 germline mutation in homozygous state in two brothers with colorectal cancers diagnosed at the age of 11 and 12 years","volume":"140","author":"M\u00fcller A","year":"2006","unstructured":"M\u00fcller A, Schackert HK, Lange B, et al.. A novel MSH2 germline mutation in homozygous state in two brothers with colorectal cancers diagnosed at the age of 11 and 12 years. Am J Med Genet A. 2006, 140:195-9. 10.1002\/ajmg.a.31070","journal-title":"Am J Med Genet A"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22697","article-title":"Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies","volume":"109","author":"Poley JW","year":"2007","unstructured":"Poley JW, Wagner A, Hoogmans MM, et al.. Biallelic germline mutations of mismatch-repair genes: a possible cause for multiple pediatric malignancies. Cancer. 2007, 109:2349-56. 10.1002\/cncr.22697","journal-title":"Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.06.030","article-title":"Low frequency of Lynch syndrome among young patients with non-familial colorectal cancer","volume":"8","author":"Goel A","year":"2010","unstructured":"Goel A, Nagasaka T, Spiegel J, Meyer R, Lichliter WE, Boland CR. Low frequency of Lynch syndrome among young patients with non-familial colorectal cancer. Clin Gastroenterol Hepatol. 2010, 8:966-71. 10.1016\/j.cgh.2010.06.030","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0b013e318251d8d9","article-title":"Is K-ras gene mutation a prognostic factor for colorectal cancer: a systematic review and meta-analysis","volume":"55","author":"Ren J","year":"2012","unstructured":"Ren J, Li G, Ge J, Li X, Zhao Y. Is K-ras gene mutation a prognostic factor for colorectal cancer: a systematic review and meta-analysis. Dis Colon Rectum. 2012, 55:913-23. 10.1097\/DCR.0b013e318251d8d9","journal-title":"Dis Colon Rectum"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-007-0650-5","article-title":"Lynch syndrome in a 15-year-old boy","volume":"167","author":"Bodas A","year":"2008","unstructured":"Bodas A, P\u00e9rez-Segura P, Maluenda C, Cald\u00e9s T, Olivera E, D\u00edaz-Rubio E. Lynch syndrome in a 15-year-old boy. Eur J Pediatr. 2008, 167:1213-5. 10.1007\/s00431-007-0650-5","journal-title":"Eur J Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21395","article-title":"Colorectal cancer statistics, 2017","volume":"67","author":"Siegel RL","year":"2017","unstructured":"Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A, Jemal A. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017, 67:177-93. 10.3322\/caac.21395","journal-title":"CA Cancer J Clin"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2017.06.002","article-title":"Early-onset olorectal cancer is distinct from traditional colorectal cancer","volume":"16","author":"Yeo H","year":"2017","unstructured":"Yeo H, Betel D, Abelson JS, Zheng XE, Yantiss R, Shah MA. Early-onset olorectal cancer is distinct from traditional colorectal cancer. Clin Colorectal Cancer. 2017, 16:293-299.e6. 10.1016\/j.clcc.2017.06.002","journal-title":"Clin Colorectal Cancer"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1674-7","article-title":"Young-onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort","volume":"18","author":"You YN","year":"2011","unstructured":"You YN, Dozois EJ, Boardman LA, Aakre J, Huebner M, Larson DW. Young-onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort. Ann Surg Oncol. 2011, 18:2469-76. 10.1245\/s10434-011-1674-7","journal-title":"Ann Surg Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.07.039","article-title":"Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome","volume":"137","author":"Stoffel E","year":"2009","unstructured":"Stoffel E, Mukherjee B, Raymond VM, et al.. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 2009, 137:1621-7. 10.1053\/j.gastro.2009.07.039","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.4280","article-title":"Association of obesity with risk of early-onset colorectal cancer among women","volume":"5","author":"Liu PH","year":"2019","unstructured":"Liu PH, Wu K, Ng K, et al.. Association of obesity with risk of early-onset colorectal cancer among women. JAMA Oncol. 2019, 5:37-44. 10.1001\/jamaoncol.2018.4280","journal-title":"JAMA Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-019-1926-2","article-title":"Colorectal cancer in inflammatory bowel disease: review of the evidence","volume":"23","author":"Keller DS","year":"2019","unstructured":"Keller DS, Windsor A, Cohen R, Chand M. Colorectal cancer in inflammatory bowel disease: review of the evidence. Tech Coloproctol. 2019, 23:3-13. 10.1007\/s10151-019-1926-2","journal-title":"Tech Coloproctol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181881354","article-title":"Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome?","volume":"87","author":"Dozois EJ","year":"2008","unstructured":"Dozois EJ, Boardman LA, Suwanthanma W, et al.. Young-onset colorectal cancer in patients with no known genetic predisposition: can we increase early recognition and improve outcome?. Medicine (Baltimore). 2008, 87:259-63. 10.1097\/MD.0b013e3181881354","journal-title":"Medicine (Baltimore)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.10.038","article-title":"Advanced-stage colorectal cancer in persons younger than 50 years not associated with longer duration of symptoms or time to diagnosis","volume":"15","author":"Chen FW","year":"2017","unstructured":"Chen FW, Sundaram V, Chew TA, Ladabaum U. Advanced-stage colorectal cancer in persons younger than 50 years not associated with longer duration of symptoms or time to diagnosis. Clin Gastroenterol Hepatol. 2017, 15:728-737.e3. 10.1016\/j.cgh.2016.10.038","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2017.07.016","article-title":"Low prevalence of criteria for early screening in young-onset colorectal cancer","volume":"53","author":"Chen FW","year":"2017","unstructured":"Chen FW, Sundaram V, Chew TA, Ladabaum U. Low prevalence of criteria for early screening in young-onset colorectal cancer. Am J Prev Med. 2017, 53:933-4. 10.1016\/j.amepre.2017.07.016","journal-title":"Am J Prev Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2003.12.020","article-title":"Colorectal cancer in the young","volume":"187","author":"O'Connell JB","year":"2004","unstructured":"O'Connell JB, Maggard MA, Livingston EH, Yo CK. Colorectal cancer in the young. Am J Surg. 2004, 187:343-8. 10.1016\/j.amjsurg.2003.12.020","journal-title":"Am J Surg"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21446","article-title":"Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening","volume":"68","author":"Smith RA","year":"2018","unstructured":"Smith RA, Andrews KS, Brooks D, et al.. Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2018, 68:297-316. 10.3322\/caac.21446","journal-title":"CA Cancer J Clin"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0021","article-title":"NCCN guidelines insights: colon cancer, version 2.2018","volume":"16","author":"Benson AB","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al.. NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw. 2018, 16:359-69. 10.6004\/jnccn.2018.0021","journal-title":"J Natl Compr Canc Netw"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0061","article-title":"Rectal cancer, version 2.2018, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Benson AB","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al.. Rectal cancer, version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018, 16:874-901. 10.6004\/jnccn.2018.0061","journal-title":"J Natl Compr Canc Netw"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0103","article-title":"A prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with young-onset colorectal cancer","volume":"13","author":"Dineen S","year":"2015","unstructured":"Dineen S, Lynch PM, Rodriguez-Bigas MA, et al.. A prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with young-onset colorectal cancer. J Natl Compr Canc Netw. 2015, 13:865-72. 10.6004\/jnccn.2015.0103","journal-title":"J Natl Compr Canc Netw"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.07.021","article-title":"Genetics and genetic testing in hereditary colorectal cancer","volume":"149","author":"Stoffel EM","year":"2015","unstructured":"Stoffel EM, Boland CR. Genetics and genetic testing in hereditary colorectal cancer. Gastroenterology. 2015, 149:1191-1203.e2. 10.1053\/j.gastro.2015.07.021","journal-title":"Gastroenterology"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility","volume":"33","author":"Robson ME","year":"2015","unstructured":"Robson ME, Bradbury AR, Arun B, et al.. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2015, 33:3660-7. 10.1200\/JCO.2015.63.0996","journal-title":"J Clin Oncol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.5194","article-title":"Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer","volume":"3","author":"Pearlman R","year":"2017","unstructured":"Pearlman R, Frankel WL, Swanson B, et al.. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2017, 3:464-71. 10.1001\/jamaoncol.2016.5194","journal-title":"JAMA Oncol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/BF02053699","article-title":"The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC)","volume":"34","author":"Vasen HF","year":"1991","unstructured":"Vasen HF, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum. 1991, 34:424-5. 10.1007\/BF02053699","journal-title":"Dis Colon Rectum"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh280","article-title":"Re: revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Laghi L","year":"2004","unstructured":"Laghi L, Bianchi P, Roncalli M, Malesci A. Re: revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004, 96:1402-3; author reply 1403-4. 10.1093\/jnci\/djh280","journal-title":"J Natl Cancer Inst"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Daly MB","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, et al.. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021, 19:77-102. 10.6004\/jnccn.2021.0001","journal-title":"J Natl Compr Canc Netw"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2006.050092","article-title":"Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers","volume":"8","author":"Murphy KM","year":"2006","unstructured":"Murphy KM, Zhang S, Geiger T, Hafez MJ, Bacher J, Berg KD, Eshleman JR. Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn. 2006, 8:305-11. 10.2353\/jmoldx.2006.050092","journal-title":"J Mol Diagn"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPB9FOVH1HGKFR","article-title":"BRAF V600E mutation analysis simplifies the testing algorithm for Lynch syndrome","volume":"140","author":"Jin M","year":"2013","unstructured":"Jin M, Hampel H, Zhou X, Schunemann L, Yearsley M, Frankel WL. BRAF V600E mutation analysis simplifies the testing algorithm for Lynch syndrome. Am J Clin Pathol. 2013, 140:177-83. 10.1309\/AJCPB9FOVH1HGKFR","journal-title":"Am J Clin Pathol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0104","article-title":"Assessment of tumor sequencing as a replacement for Lynch syndrome screening and current molecular tests for patients with colorectal cancer","volume":"4","author":"Hampel H","year":"2018","unstructured":"Hampel H, Pearlman R, Beightol M, et al.. Assessment of tumor sequencing as a replacement for Lynch syndrome screening and current molecular tests for patients with colorectal cancer. JAMA Oncol. 2018, 4:806-13. 10.1001\/jamaoncol.2018.0104","journal-title":"JAMA Oncol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2016.07.010","article-title":"Detection of mismatch repair deficiency and microsatellite instability in colorectal adenocarcinoma by targeted next-generation sequencing","volume":"19","author":"Nowak JA","year":"2017","unstructured":"Nowak JA, Yurgelun MB, Bruce JL, et al.. Detection of mismatch repair deficiency and microsatellite instability in colorectal adenocarcinoma by targeted next-generation sequencing. J Mol Diagn. 2017, 19:84-91. 10.1016\/j.jmoldx.2016.07.010","journal-title":"J Mol Diagn"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.04.001","article-title":"Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer","volume":"147","author":"Giardiello FM","year":"2014","unstructured":"Giardiello FM, Allen JI, Axilbund JE, et al.. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology. 2014, 147:502-26. 10.1053\/j.gastro.2014.04.001","journal-title":"Gastroenterology"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0176","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: colorectal, version 3.2017","volume":"15","author":"Gupta S","year":"2017","unstructured":"Gupta S, Provenzale D, Regenbogen SE, et al.. NCCN guidelines insights: genetic\/familial high-risk assessment: colorectal, version 3.2017. J Natl Compr Canc Netw. 2017, 15:1465-75. 10.6004\/jnccn.2017.0176","journal-title":"J Natl Compr Canc Netw"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.05.013","article-title":"Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer","volume":"153","author":"Rex DK","year":"2017","unstructured":"Rex DK, Boland CR, Dominitz JA, et al.. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017, 153:307-23. 10.1053\/j.gastro.2017.05.013","journal-title":"Gastroenterology"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21457","article-title":"Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society","volume":"68","author":"Wolf AM","year":"2018","unstructured":"Wolf AM, Fontham ET, Church TR, et al.. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018, 68:250-81. 10.3322\/caac.21457","journal-title":"CA Cancer J Clin"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.9901","article-title":"Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer","volume":"36","author":"Overman MJ","year":"2018","unstructured":"Overman MJ, Lonardi S, Wong KY, et al.. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J Clin Oncol. 2018, 36:773-9. 10.1200\/JCO.2017.76.9901","journal-title":"J Clin Oncol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.015","article-title":"Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers","volume":"134","author":"Schwitalle Y","year":"2008","unstructured":"Schwitalle Y, Kloor M, Eiermann S, et al.. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology. 2008, 134:988-97. 10.1053\/j.gastro.2008.01.015","journal-title":"Gastroenterology"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3051","article-title":"Correlation between density of CD8+ T-cell infiltrate in microsatellite unstable colorectal cancers and frameshift mutations: a rationale for personalized immunotherapy","volume":"75","author":"Maby P","year":"2015","unstructured":"Maby P, Tougeron D, Hamieh M, et al.. Correlation between density of CD8+ T-cell infiltrate in microsatellite unstable colorectal cancers and frameshift mutations: a rationale for personalized immunotherapy. Cancer Res. 2015, 75:3446-55. 10.1158\/0008-5472.CAN-14-3051","journal-title":"Cancer Res"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0863","article-title":"The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints","volume":"5","author":"Llosa NJ","year":"2015","unstructured":"Llosa NJ, Cruise M, Tam A, et al.. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015, 5:43-51. 10.1158\/2159-8290.CD-14-0863","journal-title":"Cancer Discov"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le DT","year":"2015","unstructured":"Le DT, Uram JN, Wang H, et al.. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015, 372:2509-20. 10.1056\/NEJMoa1500596","journal-title":"N Engl J Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le DT","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, et al.. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017, 357:409-13. 10.1126\/science.aan6733","journal-title":"Science"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman MJ","year":"2017","unstructured":"Overman MJ, McDermott R, Leach JL, et al.. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017, 18:1182-91. 10.1016\/S1470-2045(17)30422-9","journal-title":"Lancet Oncol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-014-2645-7","article-title":"Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis","volume":"19","author":"Bailey CE","year":"2015","unstructured":"Bailey CE, Tran Cao HS, Hu CY, et al.. Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis. J Gastrointest Surg. 2015, 19:180-8; discussio 188. 10.1007\/s11605-014-2645-7","journal-title":"J Gastrointest Surg"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.31.4013","article-title":"Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study","volume":"29","author":"Jansen L","year":"2011","unstructured":"Jansen L, Herrmann A, Stegmaier C, Singer S, Brenner H, Arndt V. Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study. J Clin Oncol. 2011, 29:3263-9. 10.1200\/JCO.2010.31.4013","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/204993-a-case-of-lynch-syndrome-associated-colorectal-adenocarcinoma-in-a-19-year-old-female-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:49Z","timestamp":1707509389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/204993-a-case-of-lynch-syndrome-associated-colorectal-adenocarcinoma-in-a-19-year-old-female-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":64,"URL":"https:\/\/doi.org\/10.7759\/cureus.48740","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,13]]}}}